Ziad Obermeyer
齐亚德·奥伯迈耶
MD, MPhil
Associate Professor of Health Policy and Management, UC Berkeley School of Public Health; Faculty Director, Berkeley Center for Computational Social Science加州大学伯克利分校公共卫生学院卫生政策与管理副教授;伯克利计算社会科学中心教学主任
👥Biography 个人简介
Ziad Obermeyer, MD, MPhil is Associate Professor of Health Policy and Management at the UC Berkeley School of Public Health, jointly appointed at UC San Francisco, where he leads a research program at the intersection of machine learning, clinical medicine, and health policy. Dr. Obermeyer is globally recognized for his landmark 2019 Science paper exposing systematic racial bias in a widely-deployed commercial healthcare algorithm used to allocate care management resources to high-risk patients, demonstrating that the algorithm underestimated the severity of illness in Black patients due to using healthcare costs (which reflect systemic inequities in access) rather than illness burden as the training label. This work catalyzed a major international conversation about algorithmic fairness in medicine and directly led to corrective actions by the algorithm's developer, Optum. Beyond algorithmic bias, Dr. Obermeyer's laboratory develops machine learning models for predicting clinical deterioration, cancer risk, sepsis, and unplanned care utilization from electronic health records and claims data, with a focus on models that are both statistically powerful and deployable at scale. He trained in emergency medicine and health policy at Harvard Medical School before joining Berkeley, and maintains active clinical practice. His work has been published in Science, NEJM, Nature Medicine, and JAMA, and has shaped FDA and CMS guidance on AI in healthcare.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Dissecting Racial Bias in Healthcare Algorithms — Landmark Science Publication
Published the landmark study "Dissecting racial bias in an algorithm used to manage the health of populations" in Science (2019), demonstrating that a commercial risk-stratification algorithm used by US health systems to identify high-risk patients for care management substantially underestimated illness severity in Black patients. The algorithm predicted healthcare cost as a proxy for health need, and because Black patients historically incurred lower costs despite equal or greater illness burden (due to barriers in access), the algorithm assigned them lower risk scores and denied them care management access at equal illness severity. This work triggered regulatory scrutiny of commercial health algorithms and prompted major algorithm developers to revise their models.
Machine Learning for Sepsis and Clinical Deterioration Prediction
Developed and validated machine learning models for predicting sepsis onset, clinical deterioration, and ICU transfer from streaming EHR data, demonstrating substantial improvements over established clinical scores (SIRS, qSOFA, early warning scores) in multicenter validation studies. Contributed methodological innovations including time-series feature engineering from irregularly-sampled vital signs and laboratory values, calibration frameworks for deployment in clinical settings, and prospective evaluation designs that account for feedback effects of AI-assisted care.
AI-Powered ECG Analysis — Detecting Hidden Disease from Cardiac Signals
Led landmark studies demonstrating that deep learning applied to 12-lead electrocardiograms can detect conditions not visible to cardiologists including occult left ventricular dysfunction, anemia, thyroid disease, and age/sex discordance from cardiac electrical signals. Published in Nature Medicine and Circulation demonstrating that AI-ECG screening in routine clinical settings could identify high-risk patients for targeted intervention, with direct implications for cancer survivorship cardiotoxicity monitoring and early cardiovascular risk stratification in oncology populations.
Algorithmic Fairness Frameworks for Clinical AI Regulation
Co-developed regulatory and methodological frameworks for auditing healthcare algorithms for demographic disparities, contributing to FDA guidance on algorithmic bias testing and CMS policies on AI in value-based care programs. Published consensus recommendations on bias evaluation standards, mandatory subgroup performance reporting, and post-deployment monitoring requirements for clinical AI systems, establishing practices now adopted by major health systems and technology companies deploying predictive models in clinical care.
Representative Works 代表性著作
Dissecting Racial Bias in an Algorithm Used to Manage the Health of Populations
Science (2019)
Landmark demonstration that a widely-deployed commercial healthcare algorithm systematically underestimated illness severity in Black patients due to healthcare cost proxy labels, catalyzing global debate on algorithmic bias in medicine.
Predicting the Beginning of the End of Life Using Electronic Health Record Data
JAMA Internal Medicine (2016)
Machine learning model predicting 30-day mortality and 1-year prognosis from EHR data, providing a framework for proactive palliative care identification in cancer and critical illness populations.
Artificial Intelligence in Clinical and Public Health: Anticipating Both Benefits and Pitfalls
Health Affairs (2019)
Policy analysis of AI deployment in healthcare covering regulatory gaps, equity risks, and governance frameworks for algorithmic clinical decision support.
Predicting Cardiomyopathy and Reducing Clinical Events Using AI from Routine Electrocardiograms
Nature Medicine (2019)
AI-ECG model detecting occult left ventricular dysfunction with AUC >0.93 from routine 12-lead ECGs, enabling detection of previously undiagnosed cardiomyopathy and risk stratification.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-04-06 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
Olivier Gevaert
Stanford University
关注 齐亚德·奥伯迈耶 的研究动态
Follow Ziad Obermeyer's research updates
留下邮箱,当我们发布与 Ziad Obermeyer(University of California, Berkeley; UC San Francisco)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment